Director, New Product Introduction (NPI)
Boost your chances before you apply.
WuXi AppTec
Middletown, DE, US
Summary
Lead the end-to-end technology transfer of late-phase and commercial drug products into the Middletown facility. Manage the NPI team and act as the primary technical contact for clients to ensure on-time delivery of clinical and commercial batches.
Job Description
Overview
About the Role: Are you a seasoned pharmaceutical technical leader looking to make a significant impact at a growing manufacturing site? We are seeking an Associate Director /
Director of New Product Introduction (NPI) to join our team in Middletown, Delaware.
In this critical leadership role, you will leverage your deep Drug Product (DP) technical expertise to ensure the successful technology transfer and introduction of late-phase and commercial drug products to our facility. You will lead and mentor a dedicated NPI team, guiding cross-functional groups to seamlessly transition products from development or external sites into clinical and commercial manufacturing, ensuring on-time-in-full (OTIF) execution.
Responsibilities
Technical Leadership & Tech Transfer
- Lead the end-to-end technology transfer process from internal development sites, client sites, or third-party facilities into the Middletown site.
- Experience with Oral Solid Dosage (OSD) is a must; experience with injectables is a plus.
- Select, evaluate, and scale process technology, tooling, and methods.
- Develop and optimize critical process parameters (CPPs) and critical quality attributes (CQAs).
- Troubleshoot production batches, support complex deviations, and provide technical guidance to ensure cGMP compliance and high safety standards.
Project & Client Management
- Ensure the on-time delivery of technical, registration, clinical, stability, PPQ, and commercial launch batches.
- Act as the primary site contact for clients regarding NPI, fostering strong relationships through proactive communication, risk mitigation, and a “can-do” attitude.
- Understand client needs and align them with the site’s capabilities and strengths to deliver robust solutions.
Team Leadership & Strategy
- Guide, mentor, and develop the NPI team, fostering an environment of trust and personal accountability.
- Align with site leadership to set strategic priorities, drive continuous improvement in NPI business processes, and establish/monitor team KPIs.
- Ensure roles and responsibilities are clear across matrixed project teams.
Validation & Commercial Readiness
- Collaborate with Technical Operations and Production teams to support process validation (PPQ) strategy and execution.
- Support Continued Process Verification (CPV) and commercial launch readiness.
- Act as a Subject Matter Expert (SME) during Pre-Approval Inspections (PAI) to ensure regulatory readiness.
Qualifications
- Education: Bachelor’s degree or above in Pharmaceutical Sciences, Chemical Engineering, Chemistry, or a related scientific/engineering discipline.
- Experience: 10-15+ years of pharmaceutical industry experience in Technical Operations, R&D, MS&T, or NPI management.
- Leadership: 3+ years of leadership experience with a strong focus on Drug Product processes, technology transfer, and scale-up.
- Technical Knowledge: Deep understanding of late-phase and commercial drug product manufacturing requirements.
- Regulatory Knowledge: Working knowledge of global regulatory requirements (FDA, EMA, etc.), cGMPs, ICH guidelines, and best practices (including SUPAC).
- Skills: Exceptional communication, stakeholder management, and matrix leadership skills. Excellent organizational and project management skills (PMP certification is a plus). Fluent in English.
- Work Style: Thrives in a fast-paced, dynamic environment and is comfortable navigating the ambiguity of a growing site.
Why Join Us? This is a unique opportunity to shape the NPI strategy and drive commercial success at a rapidly growing facility. If you are passionate about bringing life-changing products to market and leading high-performing technical teams, we want to hear from you!
An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status, and will not be discriminated against on the basis of disability.
This job description does not state or imply that the above are the only duties and responsibilities assigned to this position. Employees holding this position will be required to perform any other job-related duties as requested by Management.
Established in December 2000, WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States.
WuXi AppTec has successfully established a fully integrated services and technology platform during the past decade. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services.
WuXi AppTec has developed from four founders and a single laboratory in December 2000 to 10,000 employees and 5 million square feet of laboratory and manufacturing space, including facilities under construction. The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the great advantage of conducting R&D services both in China and in the U.S., WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.
药明康德新药开发有限公司于2000年12月成立,是全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司,在中美两国均有运营实体。
十多年来,药明康德成功打造了全方位一体化的研发服务技术平台。创建之初,药明康德凭借其在发现化学合成领域的雄厚实力实现了全面发展。近几年来,我们又新增了一系列一体化服务,包括分析服务、生物分析服务、工艺研究、工艺研发服务、API生产服务、药物代谢及其动力学服务、研发生物学、药理学、制剂、毒理学、基因组服务、生物制剂生产服务、抗体及生物诊断试剂的生产和销售服务以及临床研发和产品注册服务等。
从 2000 年 12 月创立至今,药明康德的员工数从4 人增长至 10000 人,实验室由当初仅有的一间增长到近46 万平方米已有及在建研发基地和生产厂房。与此同时,药明康德还在不断增强服务能力,拓宽服务领域,以更好地服务公司持续增长的全球业务需求。作为一家全球领先的医药研发服务公司,药明康德将继续致力于在中美两国为全球客户提供高质量的医药研发服务,帮助研发出更多造福患者的新药及产品。
Company size
10,001+ employees
Industry
Pharmaceutical Manufacturing
Org type
Privately Held
Headquarters
Shanghai
Established in December 2000, WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States.
WuXi AppTec has successfully established a fully integrated services and technology platform during the past decade. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services.
WuXi AppTec has developed from four founders and a single laboratory in December 2000 to 10,000 employees and 5 million square feet of laboratory and manufacturing space, including facilities under construction. The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the great advantage of conducting R&D services both in China and in the U.S., WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.
药明康德新药开发有限公司于2000年12月成立,是全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司,在中美两国均有运营实体。
十多年来,药明康德成功打造了全方位一体化的研发服务技术平台。创建之初,药明康德凭借其在发现化学合成领域的雄厚实力实现了全面发展。近几年来,我们又新增了一系列一体化服务,包括分析服务、生物分析服务、工艺研究、工艺研发服务、API生产服务、药物代谢及其动力学服务、研发生物学、药理学、制剂、毒理学、基因组服务、生物制剂生产服务、抗体及生物诊断试剂的生产和销售服务以及临床研发和产品注册服务等。
从 2000 年 12 月创立至今,药明康德的员工数从4 人增长至 10000 人,实验室由当初仅有的一间增长到近46 万平方米已有及在建研发基地和生产厂房。与此同时,药明康德还在不断增强服务能力,拓宽服务领域,以更好地服务公司持续增长的全球业务需求。作为一家全球领先的医药研发服务公司,药明康德将继续致力于在中美两国为全球客户提供高质量的医药研发服务,帮助研发出更多造福患者的新药及产品。
Company size
10,001+ employees
Industry
Pharmaceutical Manufacturing
Org type
Privately Held
Headquarters
Shanghai